Generate a tailored SOP for Dr. Kathleen Cooney. Improve your application with a focused, well-structured draft.
Kathleen Ann Cooney is an internationally recognized medical oncologist specializing in prostate cancer, affiliated with the Duke Cancer Institute. Her research is particularly focused on genetic epidemiology related to prostate cancer. Among her significant contributions is the discovery of the recurrent HOXB13 gene mutation that increases the likelihood of prostate cancer diagnosis, which accounts for approximately 5% of hereditary prostate cancer cases worldwide. Cooney's ongoing studies aim to identify germline mutations linked to lethal and aggressive forms of prostate cancer, with a particular focus on African American men who are disproportionately affected by this disease. She currently holds the position of George Barth Geller Distinguished Professor of Medicine at the Duke University School of Medicine, where she also serves as the Chair of the Department of Medicine and is a member of the Duke Molecular Physiology Institute. Cooney's extensive academic background includes an M.D. from the University of Pennsylvania and substantial training in internal medicine and hematology/oncology at the University of Michigan.
Duke University School of Medicine • Durham, NC
Position focused on leadership and advancements in medical oncology, particularly in the field of prostate cancer.
Duke University School of Medicine • Durham, NC
Oversaw the Department of Medicine with a mission to improve patient care and advance medical education.
Duke Cancer Institute • Durham, NC
Contributed to cutting-edge research and clinical practices in cancer treatment and management.
Department of Biomedical Engineering (MS program)